Gapping up
In reaction to strong earnings/guidance:
- NUS +16.8% (guides Q2 revs above consensus), FIZZ +8.9%, FORM +4% (guides Q2 revs above consensus), LHC +2.5% (raises 2021 guidance to factor revenue and EBITDA growth from new acquisition)
Other news:
- VERO +52.7% (receives FDA 510(k) clearance to market and sell for Venus Viva MD)
- NIO +15.5% (reports June deliveries increased 179% to 3740 vehicles)
- DCOM +15.2% (to merge with BDGE)
- GNW +3.8% (to host special topics call)
- JBLU +3.3% (reaches agreement with pilots' labor union, per CNBC)
- COTY +3% (names Sue Y. Nabi Chief Executive Officer; Peter Harf, founder of the modern Coty, to be elevated to Executive Chairman)
- VNE +2.7% (finalizes the split of its JV, Zenuity, with Volvo Cars)
- PCG +2.5% (emerges from Chapter 11)
- CYDY +1.9% (releases mechanism of action animation for leronlimab in immuno-oncology)
- BA +1.9% (completed the certification flight tests on the Boeing 737 MAX)
- MAXR +1.9% (completion of Vricon Acquisition)
- GS +1.4% (files mixed securities shelf offering)
- SRPT +1.2% (announces agreement with Hansa Biopharma)
Analyst comments:
- CAR +6.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- TTMI +6% (upgraded to Buy from Hold at Needham)
- HIBB +5.7% (upgraded to Buy from Underperform at BofA Securities)
- AKAM +3.5% (upgraded to Outperform from Market Perform at Cowen)
- CRH +2.1% (upgraded to Outperform from Neutral at Credit Suisse)